Association of suPAR, Galectin-3, and ST2 With CKD Progression in Heart Failure With Reduced Ejection Fraction

被引：0
|
作者：
Roehm, Bethany A. [1 ]
Gordon, Jonathan [1 ]
McAdams, Meredith C. [1 ]
Xu, Pin [1 ]
Grodin, Justin [1 ]
Hedayati, Susan [1 ]
机构：
[1] Univ Texas SouthWestern Med Ctr, Dallas, TX USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO926
引用
收藏
页码：860 / 860
页数：1
相关论文
共 50 条
  • [31] Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes
    Kim, Ae Jin
    Ro, Han
    Kim, Hyunsook
    Chang, Jae Hyun
    Lee, Hyun Hee
    Chung, Wookyung
    Jung, Ji Yong
    AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (02) : 119 - 130
  • [32] Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction
    Kanukurti, Jyothirmayi
    Mohammed, Noorjahan
    Sreedevi, N. N.
    Khan, Siraj Ahmed
    Baba, K. S. S. Sai
    Bhaskar, M. Vijaya
    Satish, O. Sai
    Naushad, Shaik Mohammad
    Mohan, Iyyapu Krishna
    JOURNAL OF LABORATORY PHYSICIANS, 2020, 12 (02) : 126 - 132
  • [33] Analysis of the novel cardiac biomarkers ST2, GDF-15, suPAR, H-FABP and Fetuin A in patients with heart failure with reduced ejection fraction (HFrEF)
    Jirak, P.
    Lichtenauer, M.
    Wernly, B.
    Paar, V.
    Rohm, I.
    Jung, C.
    Yilmaz, A.
    Hoppe, U.
    Schulze, P. C.
    Kretzschmar, D.
    Pistulli, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S74 - S75
  • [34] Increase of CA125 in Heart Failure with reduced ejection fraction: association with cardiovascular mortality, Galectin-3 and Fibroblast Growth Factor-23
    Gruson, D. Damien
    Maisin, D.
    Ahn, S. A.
    Pouleur, A. C.
    Rousseau, M. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 80 - 80
  • [35] Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction
    Jiang, Jing
    Yang, Baojun
    Sun, Ying
    Jin, Jing
    Zhao, Zhiying
    Chen, Songming
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [36] Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction
    Beltrami, Matteo
    Ruocco, Gaetano
    Dastidar, Amardeep Ghosh
    Franci, Beatrice
    Lucani, Barbara
    Aloia, Elio
    Nuti, Ranuccio
    Palazzuoli, Alberto
    CLINICA CHIMICA ACTA, 2016, 457 : 99 - 105
  • [37] Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction
    Tyminska, Agata
    Kaplon-Cieslicka, Agnieszka
    Ozieranski, Krzysztof
    Budnik, Monika
    Wancerz, Anna
    Sypien, Piotr
    Peller, Michal
    Balsam, Pawel
    Opolski, Grzegorz
    Filipiak, Krzysztof J.
    DISEASE MARKERS, 2019, 2019
  • [38] Galectin-3 is related to right ventricular dysfunction in heart failure patients with reduced ejection fraction and may affect exercise capacity
    Beata Zaborska
    Grażyna Sygitowicz
    Krzysztof Smarż
    Ewa Pilichowska-Paszkiet
    Andrzej Budaj
    Scientific Reports, 10
  • [39] The emerging role of galectin-3 and ST2 in heart failure: Practical considerations and pitfalls using novel biomarkers
    Karayannis G.
    Triposkiadis F.
    Skoularigis J.
    Georgoulias P.
    Butler J.
    Giamouzis G.
    Current Heart Failure Reports, 2013, 10 (4) : 441 - 449
  • [40] Exploring the Causal Effects of Circulating ST2 and Galectin-3 on Heart Failure Risk: A Mendelian Randomization Study
    Wang, Xizhi
    Wang, Xingchen
    Zhu, Jun
    Liu, Yu
    Zhuang, Lenan
    Zhang, Zhe
    Zhong, Danfeng
    Zhang, Wenbin
    Lai, Dongwu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345